Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Travera logo — Revolutionizing Cancer Therapy Guidance.

Travera

Revolutionizing Cancer Therapy Guidance.

Founded 2017 United States Medford, United States 11 employees Non Equity Assistance Total: $13.63M Biotechnology, Health Care +1

General Information

Company Name Travera
Founded Year 2017
Location United States Medford, United States
Founders / Decision Makers
Team member
Employees 11
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with Travera. To contact Travera, visit travera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Travera

Travera, with the slogan "Revolutionizing Cancer Therapy Guidance", was founded in 2017 and is headquartered in the United States. The company has received non-equity assistance investment from MedTech Innovator as of 06 June 2023. Travera stands out in the biotechnology and health care industries by utilizing a breakthrough measurement tool developed at MIT to directly measure the effectiveness of cancer drugs for individual patients before the drugs are administered. The company offers CLIA certified Rapid Therapy Guidance Tests for all major cancers and over 100 FDA-approved cancer drugs, providing results in just two days. With its innovative approach, Travera is poised to significantly impact the field of cancer therapy by providing personalized drug effectiveness assessments. This pioneering technology has the potential to enhance patient care and treatment outcomes in the fight against cancer.

Taxonomy: Cancer Therapy, Precision Medicine, Biomarker Detection, MIT Innovation, Medical Technology, Personalized Medicine, Drug Sensitivity Testing, Cellular Analysis, Innovative Healthcare, CAM (Cell-Attribute Monitoring), Data-driven Cancer Treatment, Rapid Diagnostic Testing, MIT spinoff

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
MedTech Innovator
MedTech Innovator
06 Jun 2023
Series A $4.00M -
13 Jul 2021
Grant $1.00M 1
National Science Foundation
National Science Foundation
11 Sep 2020
Grant $225.00K 1
National Science Foundation
National Science Foundation
01 Feb 2019
Venture Round $8.41M -
15 Jun 2018

Travera Alternatives & Competitors

Travera vs
ASC Oncology GmbH
ASC Oncology GmbH Germany

RETHINK ONCOLOGY

7 employees
Biotechnology, Health Care
Travera vs
bioAffinity Technologies
bioAffinity Technologies United States

Addressing a critical need to find cancer early and treat cancer at the cellular level.

Post-IPO Equity
22 employees
Biotechnology, Health Care
Travera vs
Cleveland Diagnostics
Cleveland Diagnostics United States

Cleveland Diagnostics is a cancer biotechnology company that is changing the shape of cancer detecti...

Private Equity
76 employees
Biotechnology, Health Care

FAQ About Travera

Revolutionizing Cancer Therapy Guidance.
Travera was founded in 2017.
Travera is headquartered in Medford, United States.
Travera operates in Biotechnology, Health Care and Life Sciences. Its work centres on Cancer Therapy, Precision Medicine, Biomarker Detection and MIT Innovation.
Travera has approximately 11 employees.
Travera has completed 5 funding rounds, raising a total of $13.63M. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to Travera include ASC Oncology GmbH, bioAffinity Technologies, Cleveland Diagnostics, OnKure Therapeutics, CCG.ai (acquired by Dante Labs). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Travera and ASC Oncology GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Travera, https://bouncewatch.com/company/travera, updated 25 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes